APO Research
Talk to an analyst

APO RESEARCH · REPORT

Contraceptive Injectable

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Contraceptive Injectable Market Analysis and Forecast 2026-2032

21 December 2025193 pages

Choose your research edition.

Industry ResearchContraceptive Injectable Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Contraceptive Injectable Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Contraceptive Injectable Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contraceptive Injectable Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Contraceptive Injectable Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Contraceptive Injectable market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Contraceptive Injectable is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Contraceptive Injectable is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Contraceptive Injectable is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Contraceptive Injectable is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Contraceptive Injectable include Janssen Pharmaceuticals, Inc., Pfizer Inc., China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu), Bayer AG, Veru, Inc., Organon Group Of Companies, Church & Dwight, Agile Therapeutics and Afaxys, Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Contraceptive Injectable, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Contraceptive Injectable, also provides the sales of main regions and countries. Of the upcoming market potential for Contraceptive Injectable, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Contraceptive Injectable sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Contraceptive Injectable market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Contraceptive Injectable sales, projected growth trends, production technology, application and end-user industry.

Contraceptive Injectable Segment by Company

Janssen Pharmaceuticals, Inc.

Pfizer Inc.

China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)

Bayer AG

Veru, Inc.

Organon Group Of Companies

Church & Dwight

Agile Therapeutics

Afaxys, Inc.

Contraceptive Injectable Segment by Type

Long-Acting Contraception

Short-Acting Contraception

Contraceptive Injectable Segment by Application

Male

Female

Contraceptive Injectable Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptive Injectable market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contraceptive Injectable and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptive Injectable.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Contraceptive Injectable in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Contraceptive Injectable manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Contraceptive Injectable sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Contraceptive Injectable Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Long-Acting Contraception Major Manufacturers Table 3. Short-Acting Contraception Major Manufacturers Table 4. Global Contraceptive Injectable Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Male Major Manufacturers Table 6. Female Major Manufacturers Table 7. Contraceptive Injectable Industry Trends Table 8. Contraceptive Injectable Industry Drivers Table 9. Contraceptive Injectable Industry Opportunities and Challenges Table 10. Contraceptive Injectable Industry Restraints Table 11. Global Contraceptive Injectable Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Contraceptive Injectable Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Contraceptive Injectable Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Contraceptive Injectable Revenue Market Share by Region (2021-2026) Table 15. Global Contraceptive Injectable Revenue Market Share by Region (2027-2032) Table 16. Global Contraceptive Injectable Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Contraceptive Injectable Sales by Region (2021-2026) & (k units) Table 18. Global Contraceptive Injectable Sales by Region (2027-2032) & (k units) Table 19. Global Contraceptive Injectable Sales Market Share by Region (2021-2026) Table 20. Global Contraceptive Injectable Sales Market Share by Region (2027-2032) Table 21. Global Contraceptive Injectable Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Contraceptive Injectable Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Contraceptive Injectable Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Contraceptive Injectable Sales Market Share by Manufacturers (2021-2026) Table 25. Global Contraceptive Injectable Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Contraceptive Injectable Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Contraceptive Injectable Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Contraceptive Injectable Manufacturers, Product Type & Application Table 29. Global Contraceptive Injectable Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Contraceptive Injectable by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Contraceptive Injectable Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Contraceptive Injectable Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Contraceptive Injectable Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Contraceptive Injectable Revenue Market Share by Type (2021-2026) Table 36. Global Contraceptive Injectable Revenue Market Share by Type (2027-2032) Table 37. Global Contraceptive Injectable Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Contraceptive Injectable Sales by Type (2021-2026) & (k units) Table 39. Global Contraceptive Injectable Sales by Type (2027-2032) & (k units) Table 40. Global Contraceptive Injectable Sales Market Share by Type (2021-2026) Table 41. Global Contraceptive Injectable Sales Market Share by Type (2027-2032) Table 42. Global Contraceptive Injectable Price by Type (2021-2026) & (US$/unit) Table 43. Global Contraceptive Injectable Price by Type (2027-2032) & (US$/unit) Table 44. Global Contraceptive Injectable Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Contraceptive Injectable Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Contraceptive Injectable Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Contraceptive Injectable Revenue Market Share by Application (2021-2026) Table 48. Global Contraceptive Injectable Revenue Market Share by Application (2027-2032) Table 49. Global Contraceptive Injectable Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Contraceptive Injectable Sales by Application (2021-2026) & (k units) Table 51. Global Contraceptive Injectable Sales by Application (2027-2032) & (k units) Table 52. Global Contraceptive Injectable Sales Market Share by Application (2021-2026) Table 53. Global Contraceptive Injectable Sales Market Share by Application (2027-2032) Table 54. Global Contraceptive Injectable Price by Application (2021-2026) & (US$/unit) Table 55. Global Contraceptive Injectable Price by Application (2027-2032) & (US$/unit) Table 56. Janssen Pharmaceuticals, Inc. Company Information Table 57. Janssen Pharmaceuticals, Inc. Business Overview Table 58. Janssen Pharmaceuticals, Inc. Contraceptive Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Janssen Pharmaceuticals, Inc. Contraceptive Injectable Product Portfolio Table 60. Janssen Pharmaceuticals, Inc. Recent Development Table 61. Pfizer Inc. Company Information Table 62. Pfizer Inc. Business Overview Table 63. Pfizer Inc. Contraceptive Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Pfizer Inc. Contraceptive Injectable Product Portfolio Table 65. Pfizer Inc. Recent Development Table 66. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Company Information Table 67. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Business Overview Table 68. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Product Portfolio Table 70. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Recent Development Table 71. Bayer AG Company Information Table 72. Bayer AG Business Overview Table 73. Bayer AG Contraceptive Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Bayer AG Contraceptive Injectable Product Portfolio Table 75. Bayer AG Recent Development Table 76. Veru, Inc. Company Information Table 77. Veru, Inc. Business Overview Table 78. Veru, Inc. Contraceptive Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Veru, Inc. Contraceptive Injectable Product Portfolio Table 80. Veru, Inc. Recent Development Table 81. Organon Group Of Companies Company Information Table 82. Organon Group Of Companies Business Overview Table 83. Organon Group Of Companies Contraceptive Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Organon Group Of Companies Contraceptive Injectable Product Portfolio Table 85. Organon Group Of Companies Recent Development Table 86. Church & Dwight Company Information Table 87. Church & Dwight Business Overview Table 88. Church & Dwight Contraceptive Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Church & Dwight Contraceptive Injectable Product Portfolio Table 90. Church & Dwight Recent Development Table 91. Agile Therapeutics Company Information Table 92. Agile Therapeutics Business Overview Table 93. Agile Therapeutics Contraceptive Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Agile Therapeutics Contraceptive Injectable Product Portfolio Table 95. Agile Therapeutics Recent Development Table 96. Afaxys, Inc. Company Information Table 97. Afaxys, Inc. Business Overview Table 98. Afaxys, Inc. Contraceptive Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Afaxys, Inc. Contraceptive Injectable Product Portfolio Table 100. Afaxys, Inc. Recent Development Table 101. North America Contraceptive Injectable Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Contraceptive Injectable Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Contraceptive Injectable Sales by Type (2021-2026) & (k units) Table 104. North America Contraceptive Injectable Sales by Type (2027-2032) & (k units) Table 105. North America Contraceptive Injectable Sales Price by Type (2021-2026) & (US$/unit) Table 106. North America Contraceptive Injectable Sales Price by Type (2027-2032) & (US$/unit) Table 107. North America Contraceptive Injectable Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Contraceptive Injectable Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Contraceptive Injectable Sales by Application (2021-2026) & (k units) Table 110. North America Contraceptive Injectable Sales by Application (2027-2032) & (k units) Table 111. North America Contraceptive Injectable Sales Price by Application (2021-2026) & (US$/unit) Table 112. North America Contraceptive Injectable Sales Price by Application (2027-2032) & (US$/unit) Table 113. North America Contraceptive Injectable Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Contraceptive Injectable Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 115. North America Contraceptive Injectable Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 116. North America Contraceptive Injectable Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 117. North America Contraceptive Injectable Sales by Country (2021-2026) & (k units) Table 118. North America Contraceptive Injectable Sales by Country (2027-2032) & (k units) Table 119. North America Contraceptive Injectable Sales Price by Country (2021-2026) & (US$/unit) Table 120. North America Contraceptive Injectable Sales Price by Country (2027-2032) & (US$/unit) Table 121. United States Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 122. Canada Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 123. Mexico Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 124. Europe Contraceptive Injectable Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Contraceptive Injectable Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Contraceptive Injectable Sales by Type (2021-2026) & (k units) Table 127. Europe Contraceptive Injectable Sales by Type (2027-2032) & (k units) Table 128. Europe Contraceptive Injectable Sales Price by Type (2021-2026) & (US$/unit) Table 129. Europe Contraceptive Injectable Sales Price by Type (2027-2032) & (US$/unit) Table 130. Europe Contraceptive Injectable Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Contraceptive Injectable Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Contraceptive Injectable Sales by Application (2021-2026) & (k units) Table 133. Europe Contraceptive Injectable Sales by Application (2027-2032) & (k units) Table 134. Europe Contraceptive Injectable Sales Price by Application (2021-2026) & (US$/unit) Table 135. Europe Contraceptive Injectable Sales Price by Application (2027-2032) & (US$/unit) Table 136. Europe Contraceptive Injectable Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Contraceptive Injectable Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. Europe Contraceptive Injectable Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. Europe Contraceptive Injectable Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 140. Europe Contraceptive Injectable Sales by Country (2021-2026) & (k units) Table 141. Europe Contraceptive Injectable Sales by Country (2027-2032) & (k units) Table 142. Europe Contraceptive Injectable Sales Price by Country (2021-2026) & (US$/unit) Table 143. Europe Contraceptive Injectable Sales Price by Country (2027-2032) & (US$/unit) Table 144. Germany Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 145. France Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 146. U.K. Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 147. Italy Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 148. Russia Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 149. Spain Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 150. Netherlands Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 151. Switzerland Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 152. Sweden Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 153. Poland Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 154. China Contraceptive Injectable Revenue by Type (2021-2026) & (US$ Million) Table 155. China Contraceptive Injectable Revenue by Type (2027-2032) & (US$ Million) Table 156. China Contraceptive Injectable Sales by Type (2021-2026) & (k units) Table 157. China Contraceptive Injectable Sales by Type (2027-2032) & (k units) Table 158. China Contraceptive Injectable Sales Price by Type (2021-2026) & (US$/unit) Table 159. China Contraceptive Injectable Sales Price by Type (2027-2032) & (US$/unit) Table 160. China Contraceptive Injectable Revenue by Application (2021-2026) & (US$ Million) Table 161. China Contraceptive Injectable Revenue by Application (2027-2032) & (US$ Million) Table 162. China Contraceptive Injectable Sales by Application (2021-2026) & (k units) Table 163. China Contraceptive Injectable Sales by Application (2027-2032) & (k units) Table 164. China Contraceptive Injectable Sales Price by Application (2021-2026) & (US$/unit) Table 165. China Contraceptive Injectable Sales Price by Application (2027-2032) & (US$/unit) Table 166. Asia Contraceptive Injectable Revenue by Type (2021-2026) & (US$ Million) Table 167. Asia Contraceptive Injectable Revenue by Type (2027-2032) & (US$ Million) Table 168. Asia Contraceptive Injectable Sales by Type (2021-2026) & (k units) Table 169. Asia Contraceptive Injectable Sales by Type (2027-2032) & (k units) Table 170. Asia Contraceptive Injectable Sales Price by Type (2021-2026) & (US$/unit) Table 171. Asia Contraceptive Injectable Sales Price by Type (2027-2032) & (US$/unit) Table 172. Asia Contraceptive Injectable Revenue by Application (2021-2026) & (US$ Million) Table 173. Asia Contraceptive Injectable Revenue by Application (2027-2032) & (US$ Million) Table 174. Asia Contraceptive Injectable Sales by Application (2021-2026) & (k units) Table 175. Asia Contraceptive Injectable Sales by Application (2027-2032) & (k units) Table 176. Asia Contraceptive Injectable Sales Price by Application (2021-2026) & (US$/unit) Table 177. Asia Contraceptive Injectable Sales Price by Application (2027-2032) & (US$/unit) Table 178. Asia Contraceptive Injectable Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Asia Contraceptive Injectable Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Asia Contraceptive Injectable Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Asia Contraceptive Injectable Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 182. Asia Contraceptive Injectable Sales by Country (2021-2026) & (k units) Table 183. Asia Contraceptive Injectable Sales by Country (2027-2032) & (k units) Table 184. Asia Contraceptive Injectable Sales Price by Country (2021-2026) & (US$/unit) Table 185. Asia Contraceptive Injectable Sales Price by Country (2027-2032) & (US$/unit) Table 186. Japan Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 187. South Korea Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 188. India Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 189. Australia Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 190. Taiwan Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 191. Southeast Asia Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 192. SAMEA Contraceptive Injectable Revenue by Type (2021-2026) & (US$ Million) Table 193. SAMEA Contraceptive Injectable Revenue by Type (2027-2032) & (US$ Million) Table 194. SAMEA Contraceptive Injectable Sales by Type (2021-2026) & (k units) Table 195. SAMEA Contraceptive Injectable Sales by Type (2027-2032) & (k units) Table 196. SAMEA Contraceptive Injectable Sales Price by Type (2021-2026) & (US$/unit) Table 197. SAMEA Contraceptive Injectable Sales Price by Type (2027-2032) & (US$/unit) Table 198. SAMEA Contraceptive Injectable Revenue by Application (2021-2026) & (US$ Million) Table 199. SAMEA Contraceptive Injectable Revenue by Application (2027-2032) & (US$ Million) Table 200. SAMEA Contraceptive Injectable Sales by Application (2021-2026) & (k units) Table 201. SAMEA Contraceptive Injectable Sales by Application (2027-2032) & (k units) Table 202. SAMEA Contraceptive Injectable Sales Price by Application (2021-2026) & (US$/unit) Table 203. SAMEA Contraceptive Injectable Sales Price by Application (2027-2032) & (US$/unit) Table 204. SAMEA Contraceptive Injectable Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. SAMEA Contraceptive Injectable Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. SAMEA Contraceptive Injectable Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. SAMEA Contraceptive Injectable Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 208. SAMEA Contraceptive Injectable Sales by Country (2021-2026) & (k units) Table 209. SAMEA Contraceptive Injectable Sales by Country (2027-2032) & (k units) Table 210. SAMEA Contraceptive Injectable Sales Price by Country (2021-2026) & (US$/unit) Table 211. SAMEA Contraceptive Injectable Sales Price by Country (2027-2032) & (US$/unit) Table 212. Brazil Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 213. Argentina Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 214. Chile Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 215. Colombia Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 216. Peru Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 217. Saudi Arabia Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 218. Israel Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 219. UAE Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 220. Turkey Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 221. Iran Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 222. Egypt Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Table 223. Key Raw Materials Table 224. Raw Materials Key Suppliers Table 225. Contraceptive Injectable Distributors List Table 226. Contraceptive Injectable Customers List Table 227. Research Programs/Design for This Report Table 228. Authors List of This Report Table 229. Secondary Sources Table 230. Primary Sources List of Figures Figure 1. Contraceptive Injectable Image Figure 2. Global Contraceptive Injectable Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contraceptive Injectable Market Size Share 2021 VS 2025 VS 2032 Figure 4. Long-Acting Contraception Image Figure 5. Short-Acting Contraception Image Figure 6. Global Contraceptive Injectable Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Contraceptive Injectable Market Size Share 2021 VS 2025 VS 2032 Figure 8. Male Image Figure 9. Female Image Figure 10. Global Contraceptive Injectable Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Contraceptive Injectable Revenue (2021-2032) & (US$ Million) Figure 12. Global Contraceptive Injectable Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Contraceptive Injectable Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Contraceptive Injectable Revenue Market Share by Region (2021-2032) Figure 15. Global Contraceptive Injectable Sales (2021-2032) & (k units) Figure 16. Global Contraceptive Injectable Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Contraceptive Injectable Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Contraceptive Injectable Sales YoY (2021-2032) & (k units) Figure 19. Europe Contraceptive Injectable Sales YoY (2021-2032) & (k units) Figure 20. China Contraceptive Injectable Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Contraceptive Injectable Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Contraceptive Injectable Sales YoY (2021-2032) & (k units) Figure 23. Global Contraceptive Injectable Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Contraceptive Injectable Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Contraceptive Injectable Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Contraceptive Injectable Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Contraceptive Injectable Revenue Market Share by Type (2021-2032) Figure 29. Global Contraceptive Injectable Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Contraceptive Injectable Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Contraceptive Injectable Sales Market Share by Type (2021-2032) Figure 32. Global Contraceptive Injectable Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Contraceptive Injectable Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Contraceptive Injectable Revenue Market Share by Application (2021-2032) Figure 35. Global Contraceptive Injectable Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Contraceptive Injectable Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Contraceptive Injectable Sales Market Share by Application (2021-2032) Figure 38. North America Contraceptive Injectable Revenue Share by Type (2021-2032) Figure 39. North America Contraceptive Injectable Sales Share by Type (2021-2032) Figure 40. North America Contraceptive Injectable Revenue Share by Application (2021-2032) Figure 41. North America Contraceptive Injectable Sales Share by Application (2021-2032) Figure 42. North America Contraceptive Injectable Revenue Share by Country (2021-2032) Figure 43. North America Contraceptive Injectable Sales Share by Country (2021-2032) Figure 44. Europe Contraceptive Injectable Revenue Share by Type (2021-2032) Figure 45. Europe Contraceptive Injectable Sales Share by Type (2021-2032) Figure 46. Europe Contraceptive Injectable Revenue Share by Application (2021-2032) Figure 47. Europe Contraceptive Injectable Sales Share by Application (2021-2032) Figure 48. Europe Contraceptive Injectable Revenue Share by Country (2021-2032) Figure 49. Europe Contraceptive Injectable Sales Share by Country (2021-2032) Figure 50. China Contraceptive Injectable Revenue Share by Type (2021-2032) Figure 51. China Contraceptive Injectable Sales Share by Type (2021-2032) Figure 52. China Contraceptive Injectable Revenue Share by Application (2021-2032) Figure 53. China Contraceptive Injectable Sales Share by Application (2021-2032) Figure 54. Asia Contraceptive Injectable Revenue Share by Type (2021-2032) Figure 55. Asia Contraceptive Injectable Sales Share by Type (2021-2032) Figure 56. Asia Contraceptive Injectable Revenue Share by Application (2021-2032) Figure 57. Asia Contraceptive Injectable Sales Share by Application (2021-2032) Figure 58. Asia Contraceptive Injectable Revenue Share by Country (2021-2032) Figure 59. Asia Contraceptive Injectable Sales Share by Country (2021-2032) Figure 60. SAMEA Contraceptive Injectable Revenue Share by Type (2021-2032) Figure 61. SAMEA Contraceptive Injectable Sales Share by Type (2021-2032) Figure 62. SAMEA Contraceptive Injectable Revenue Share by Application (2021-2032) Figure 63. SAMEA Contraceptive Injectable Sales Share by Application (2021-2032) Figure 64. SAMEA Contraceptive Injectable Revenue Share by Country (2021-2032) Figure 65. SAMEA Contraceptive Injectable Sales Share by Country (2021-2032) Figure 66. Contraceptive Injectable Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Contraceptive Injectable Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Long-Acting Contraception
  • Short-Acting Contraception
Applications
  • Male
  • Female
Companies covered
  • Janssen Pharmaceuticals, Inc.
  • Pfizer Inc.
  • China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
  • Bayer AG
  • Veru, Inc.
  • Organon Group Of Companies
  • Church & Dwight
  • Agile Therapeutics
  • Afaxys, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Contraceptive Injectable Market by Type
  3. 1.2.1 Global Contraceptive Injectable Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Long-Acting Contraception
  5. 1.2.3 Short-Acting Contraception
  6. 1.3 Contraceptive Injectable Market by Application
  7. 1.3.1 Global Contraceptive Injectable Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Male
  9. 1.3.3 Female
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Contraceptive Injectable Market Dynamics
  1. 2.1 Contraceptive Injectable Industry Trends
  2. 2.2 Contraceptive Injectable Industry Drivers
  3. 2.3 Contraceptive Injectable Industry Opportunities and Challenges
  4. 2.4 Contraceptive Injectable Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Contraceptive Injectable Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Contraceptive Injectable Revenue by Region
  3. 3.2.1 Global Contraceptive Injectable Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Contraceptive Injectable Revenue by Region (2021-2026)
  5. 3.2.3 Global Contraceptive Injectable Revenue by Region (2027-2032)
  6. 3.2.4 Global Contraceptive Injectable Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Contraceptive Injectable Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Contraceptive Injectable Sales by Region
  9. 3.4.1 Global Contraceptive Injectable Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Contraceptive Injectable Sales by Region (2021-2026)
  11. 3.4.3 Global Contraceptive Injectable Sales by Region (2027-2032)
  12. 3.4.4 Global Contraceptive Injectable Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Contraceptive Injectable Revenue by Manufacturers
  2. 4.1.1 Global Contraceptive Injectable Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Contraceptive Injectable Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Contraceptive Injectable Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Contraceptive Injectable Sales by Manufacturers
  6. 4.2.1 Global Contraceptive Injectable Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Contraceptive Injectable Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Contraceptive Injectable Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Contraceptive Injectable Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Contraceptive Injectable Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Contraceptive Injectable Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Contraceptive Injectable Manufacturers, Product Type & Application
  13. 4.7 Global Contraceptive Injectable Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Contraceptive Injectable Market CR5 and HHI
  16. 4.8.2 2025 Contraceptive Injectable Tier 1, Tier 2, and Tier 3
5 Contraceptive Injectable Market by Type
  1. 5.1 Global Contraceptive Injectable Revenue by Type
  2. 5.1.1 Global Contraceptive Injectable Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Contraceptive Injectable Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Contraceptive Injectable Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Contraceptive Injectable Sales by Type
  6. 5.2.1 Global Contraceptive Injectable Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Contraceptive Injectable Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Contraceptive Injectable Sales Market Share by Type (2021-2032)
  9. 5.3 Global Contraceptive Injectable Price by Type
6 Contraceptive Injectable Market by Application
  1. 6.1 Global Contraceptive Injectable Revenue by Application
  2. 6.1.1 Global Contraceptive Injectable Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Contraceptive Injectable Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Contraceptive Injectable Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Contraceptive Injectable Sales by Application
  6. 6.2.1 Global Contraceptive Injectable Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Contraceptive Injectable Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Contraceptive Injectable Sales Market Share by Application (2021-2032)
  9. 6.3 Global Contraceptive Injectable Price by Application
7 Company Profiles
  1. 7.1 Janssen Pharmaceuticals, Inc.
  2. 7.1.1 Janssen Pharmaceuticals, Inc. Company Information
  3. 7.1.2 Janssen Pharmaceuticals, Inc. Business Overview
  4. 7.1.3 Janssen Pharmaceuticals, Inc. Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Janssen Pharmaceuticals, Inc. Contraceptive Injectable Product Portfolio
  6. 7.1.5 Janssen Pharmaceuticals, Inc. Recent Developments
  7. 7.2 Pfizer Inc.
  8. 7.2.1 Pfizer Inc. Company Information
  9. 7.2.2 Pfizer Inc. Business Overview
  10. 7.2.3 Pfizer Inc. Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Inc. Contraceptive Injectable Product Portfolio
  12. 7.2.5 Pfizer Inc. Recent Developments
  13. 7.3 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
  14. 7.3.1 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Company Information
  15. 7.3.2 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Business Overview
  16. 7.3.3 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Product Portfolio
  18. 7.3.5 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Recent Developments
  19. 7.4 Bayer AG
  20. 7.4.1 Bayer AG Company Information
  21. 7.4.2 Bayer AG Business Overview
  22. 7.4.3 Bayer AG Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bayer AG Contraceptive Injectable Product Portfolio
  24. 7.4.5 Bayer AG Recent Developments
  25. 7.5 Veru, Inc.
  26. 7.5.1 Veru, Inc. Company Information
  27. 7.5.2 Veru, Inc. Business Overview
  28. 7.5.3 Veru, Inc. Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Veru, Inc. Contraceptive Injectable Product Portfolio
  30. 7.5.5 Veru, Inc. Recent Developments
  31. 7.6 Organon Group Of Companies
  32. 7.6.1 Organon Group Of Companies Company Information
  33. 7.6.2 Organon Group Of Companies Business Overview
  34. 7.6.3 Organon Group Of Companies Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Organon Group Of Companies Contraceptive Injectable Product Portfolio
  36. 7.6.5 Organon Group Of Companies Recent Developments
  37. 7.7 Church & Dwight
  38. 7.7.1 Church & Dwight Company Information
  39. 7.7.2 Church & Dwight Business Overview
  40. 7.7.3 Church & Dwight Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Church & Dwight Contraceptive Injectable Product Portfolio
  42. 7.7.5 Church & Dwight Recent Developments
  43. 7.8 Agile Therapeutics
  44. 7.8.1 Agile Therapeutics Company Information
  45. 7.8.2 Agile Therapeutics Business Overview
  46. 7.8.3 Agile Therapeutics Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Agile Therapeutics Contraceptive Injectable Product Portfolio
  48. 7.8.5 Agile Therapeutics Recent Developments
  49. 7.9 Afaxys, Inc.
  50. 7.9.1 Afaxys, Inc. Company Information
  51. 7.9.2 Afaxys, Inc. Business Overview
  52. 7.9.3 Afaxys, Inc. Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Afaxys, Inc. Contraceptive Injectable Product Portfolio
  54. 7.9.5 Afaxys, Inc. Recent Developments
8 North America
  1. 8.1 North America Contraceptive Injectable Market Size by Type
  2. 8.1.1 North America Contraceptive Injectable Revenue by Type (2021-2032)
  3. 8.1.2 North America Contraceptive Injectable Sales by Type (2021-2032)
  4. 8.1.3 North America Contraceptive Injectable Price by Type (2021-2032)
  5. 8.2 North America Contraceptive Injectable Market Size by Application
  6. 8.2.1 North America Contraceptive Injectable Revenue by Application (2021-2032)
  7. 8.2.2 North America Contraceptive Injectable Sales by Application (2021-2032)
  8. 8.2.3 North America Contraceptive Injectable Price by Application (2021-2032)
  9. 8.3 North America Contraceptive Injectable Market Size by Country
  10. 8.3.1 North America Contraceptive Injectable Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Contraceptive Injectable Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Contraceptive Injectable Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Contraceptive Injectable Market Size by Type
  2. 9.1.1 Europe Contraceptive Injectable Revenue by Type (2021-2032)
  3. 9.1.2 Europe Contraceptive Injectable Sales by Type (2021-2032)
  4. 9.1.3 Europe Contraceptive Injectable Price by Type (2021-2032)
  5. 9.2 Europe Contraceptive Injectable Market Size by Application
  6. 9.2.1 Europe Contraceptive Injectable Revenue by Application (2021-2032)
  7. 9.2.2 Europe Contraceptive Injectable Sales by Application (2021-2032)
  8. 9.2.3 Europe Contraceptive Injectable Price by Application (2021-2032)
  9. 9.3 Europe Contraceptive Injectable Market Size by Country
  10. 9.3.1 Europe Contraceptive Injectable Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Contraceptive Injectable Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Contraceptive Injectable Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Contraceptive Injectable Market Size by Type
  2. 10.1.1 China Contraceptive Injectable Revenue by Type (2021-2032)
  3. 10.1.2 China Contraceptive Injectable Sales by Type (2021-2032)
  4. 10.1.3 China Contraceptive Injectable Price by Type (2021-2032)
  5. 10.2 China Contraceptive Injectable Market Size by Application
  6. 10.2.1 China Contraceptive Injectable Revenue by Application (2021-2032)
  7. 10.2.2 China Contraceptive Injectable Sales by Application (2021-2032)
  8. 10.2.3 China Contraceptive Injectable Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Contraceptive Injectable Market Size by Type
  2. 11.1.1 Asia Contraceptive Injectable Revenue by Type (2021-2032)
  3. 11.1.2 Asia Contraceptive Injectable Sales by Type (2021-2032)
  4. 11.1.3 Asia Contraceptive Injectable Price by Type (2021-2032)
  5. 11.2 Asia Contraceptive Injectable Market Size by Application
  6. 11.2.1 Asia Contraceptive Injectable Revenue by Application (2021-2032)
  7. 11.2.2 Asia Contraceptive Injectable Sales by Application (2021-2032)
  8. 11.2.3 Asia Contraceptive Injectable Price by Application (2021-2032)
  9. 11.3 Asia Contraceptive Injectable Market Size by Country
  10. 11.3.1 Asia Contraceptive Injectable Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Contraceptive Injectable Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Contraceptive Injectable Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Contraceptive Injectable Market Size by Type
  2. 12.1.1 SAMEA Contraceptive Injectable Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Contraceptive Injectable Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Contraceptive Injectable Price by Type (2021-2032)
  5. 12.2 SAMEA Contraceptive Injectable Market Size by Application
  6. 12.2.1 SAMEA Contraceptive Injectable Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Contraceptive Injectable Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Contraceptive Injectable Price by Application (2021-2032)
  9. 12.3 SAMEA Contraceptive Injectable Market Size by Country
  10. 12.3.1 SAMEA Contraceptive Injectable Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Contraceptive Injectable Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Contraceptive Injectable Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Contraceptive Injectable Value Chain Analysis
  2. 13.1.1 Contraceptive Injectable Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Contraceptive Injectable Production Mode & Process
  6. 13.2 Contraceptive Injectable Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Contraceptive Injectable Distributors
  9. 13.2.3 Contraceptive Injectable Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst